AI Revolutionizes Cancer Treatment: A New Era in Medicine
Written on
Understanding Cancer: The Basics
Cancer is fundamentally a result of uncontrolled cell growth within the body. The process typically begins when a cell's genetic code undergoes a change, known as a mutation. This can be triggered by various factors:
- Physical: Ultraviolet (UV) rays leading to skin cancer
- Chemical: Tobacco smoke causing lung cancer
- Biological: Hepatitis B virus contributing to liver cancer
- Inherited: Genetic variations, such as BRCA mutations linked to breast cancer
These mutations can arise through two primary mechanisms: the abnormal activation of oncogenes, which promote growth, or the inactivation of tumor suppressor genes, which normally inhibit cell proliferation. These changes can initiate a chain reaction, allowing abnormal cells to thrive, multiply unchecked, and spread to other body parts in a process called metastasis.
As we delve deeper, it becomes evident that many mutations result in proteins that do not function correctly, leading to cancerous cells.
The Journey of Developing Cancer Treatments
Cancer therapies can target the abnormal proteins found in cancer cells. To achieve this, researchers must first ascertain the three-dimensional structures of these proteins, as these shapes determine their biological roles. The process, known as Structure-Based Drug Discovery (SBDD), involves several intricate steps, including the production and purification of target proteins for crystallization.
Some common techniques used to discern the 3D structures include:
- X-ray Crystallography: Analyzing diffraction patterns of X-rays through crystals to determine structure.
- Nuclear Magnetic Resonance (NMR): Utilizing the magnetic properties of atoms to identify structures.
- Cryo-Electron Microscopy: Observing frozen protein crystals with an electron microscope.
Despite its straightforward appearance, protein crystallization is a complex, time-consuming endeavor. Researchers often invest years—sometimes even decades—into a single protein, with a high likelihood of failure.
Proteins: The Building Blocks of Life
Proteins are vital macromolecules that perform essential biological functions. They are constructed from amino acids, which form long chains (the primary structure) and then fold into secondary structures like α-helices and β-sheets. These further condense into tertiary structures, ultimately assembling into quaternary structures.
The function of a protein is heavily reliant on its 3D configuration, and predicting this structure from the primary sequence is a formidable challenge. Cyrus Levinthal famously noted that an unfolded protein can have an astronomically high number of possible conformations, making proper folding a complex task. Thankfully, most proteins can self-fold in microseconds to milliseconds.
Decoding Protein Structures: The Challenge
To tackle the intricate problem of determining protein structures, biologists participate in a biennial global competition known as the Critical Assessment of Structure Prediction (CASP). The competition has historically yielded modest results, but in 2018, Google DeepMind's AlphaFold model significantly advanced the field. By 2020, an improved version, AlphaFold2, was recognized for solving the long-standing protein-folding conundrum.
In 2021, the AlphaFold team published their findings, and by 2022, they made available a public database containing nearly 1 million protein structures, accessible to researchers worldwide.
Exploring AlphaFold's Mechanism
AlphaFold1, which triumphed in CASP13 in 2018, utilized a unique architecture involving Residual Convolutional layers. Its inputs included the amino acid sequence and features derived from Multiple Sequence Alignments (MSA). The model then generated probability distributions of distances and torsion angles between amino acids, ultimately constructing the 3D structure through optimization techniques.
AlphaFold2 built upon this foundation, delivering even more accurate predictions by directly outputting the 3D structure based on the same input features while incorporating evolutionary data to enhance predictions.
AI-Driven Drug Discovery in Cancer Treatment
The groundbreaking study led by Insilico Medicine focused on hepatocellular carcinoma (HCC), a prevalent and difficult-to-treat liver cancer. Using PandaOmics, an AI-driven biocomputational tool, researchers identified 20 potential drug targets and highlighted CDK20 (Cyclin Dependent Kinase 20) as a key candidate due to its abundance in tumor cells.
The researchers utilized AlphaFold2 to predict the 3D structure of CDK20 and employed Chemistry42, another AI-powered tool, to identify compounds that could inhibit this enzyme. Among the promising candidates were ISM042–2–001 and ISM042–2–048, which showed significant effectiveness against CDK20 in lab tests.
Interestingly, ISM042–2–048 exhibited a stronger impact on cancerous cells without adversely affecting healthy ones—an ideal trait for cancer therapies.
The Role of AI in Cancer Treatment
The integration of AI in cancer drug discovery marks a revolutionary shift in modern medicine. By harnessing the power of multiple AI models, researchers have made significant strides in identifying effective treatments, paving the way for future innovations in healthcare.
This video titled "AI and Immunotherapy: A Breakthrough in Cancer Treatment" delves into how AI is transforming cancer therapies and its implications for future treatments.
The second video, "The Future of AI and Cancer Research," discusses the potential of AI in advancing cancer research and treatment methodologies.
In conclusion, the application of AI in drug discovery is nothing short of impressive. What other remarkable uses of AI in medicine have you encountered? Share your insights in the comments below!